1. In September, 2001, Sichuan Hengkang Development Co., Ltd. and Gansu Doyiwei Pharmaceutical Co., Ltd.*** jointly invested in the establishment of Gansu Doyiwei Biopharmaceutical Co.
2, in May 2002, the company invested 30 million, in strict accordance with GMP standard design, with the advanced level of the new production base in Gansu Province, Kang County, Wangba Doyiming Industrial Park completed and passed the acceptance test, *** production of 6 dosage forms, 32 varieties, a number of national new drugs, exclusive varieties and Chinese medicine to protect the varieties, with the ability to deal with the original 1500 tons of drugs per year. At the same time, the company smoothly moved from Lanzhou to Kang County, a unique flavor of bio-industrial park.
3. In October, 2003, the company passed the national GMP certification.
4. In October 2005, the company succeeded in the industrialized production of Duiyimin soft capsule, and was granted the approval for the production of new drugs.
5. In February 2006, the company successfully passed the GMP certification of the soft capsule production line workshop, laying the foundation for the large-scale production of new products.
6. In July 2006, the company succeeded in the industrialized production of Gongmu Ning capsule, and obtained the new drug production approval.
7, in 2006, the company's national production of traditional Chinese medicinal materials to support the project of artificial cultivation of Tibetan medicinal materials, and invested in Gannan Maqu County, built a planting base, covering an area of 30,000 acres, for the protection of the wild resources of the grass, and to promote the industrialization of the application of the grass is of great significance. At the same time, the company also in the national ministry of commerce to apply for a unique flavor certificate of origin, to further form a unique flavor of the exclusive advantage of the position.
8. In December 2006, the third extraordinary shareholders' meeting of 2006 was held in Chengdu, which passed the plan of overall restructuring of the company by voting. on December 29, the company was officially restructured into Gansu Doyimin Bio-Pharmaceutical Co., Ltd. and the first board of directors and supervisory board of the company were produced, and 9 directors and 3 supervisors were elected.
9, in June 2007, the company and the Chinese Medical Association Continuing Education Magazine jointly organized in Chongqing, Dalian, Beijing, Zibo and other places, "medical research thinking and paper writing class", vigorously enhance the company's visibility.
10. In March 2008, the company was listed in Shenzhen's small and medium-sized plate market, becoming the first pharmaceutical listed company in Gansu Province
11. In 2012, the company clearly defined medical services as a strategic direction, and fully involved in the medical service industry.
12, 2013, the company in the field of medical mergers and acquisitions, has acquired five hospitals.
13, in 2014, the company changed its name to Hengkang Medical to strengthen the strategic direction of medical care, began to acquire large second-class hospitals, and actively participate in the restructuring of public hospitals.